By treating the human neuroblastoma SH-SY5Y cells with all-trans RA, we observed a significant increase in the number of CD44+/CD49d+ cells, predominantly via the enhancement of CD49d expression (Fig. 3a–d; Supplementary Fig. 6). This evidence concerns the gene ITGA4 and neuroblastoma.